Baird lowered the firm’s price target on Charles River (CRL) to $173 from $177 and keeps a Neutral rating on the shares. The firm The firm updated its model following Q4 results.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRL:
- Charles River price target lowered to $160 from $166 at Barclays
- Charles River Labs: Hold Rating Amid Uncertain FY25 Outlook Due to Biopharma Demand and DSA Challenges
- Charles River Laboratories Faces Uncertainty in Achieving Cost Savings from Restructuring Efforts
- Charles River Laboratories Reports 2024 Earnings and 2025 Outlook
- Charles River Labs: Mixed Signals in Earnings Call